Literature DB >> 2017233

Immunosuppression in aplastic anemia--postponing the inevitable?

M A Moore, H Castro-Malaspina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2017233     DOI： 10.1056/NEJM199105093241909

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Felbamate in epilepsy therapy: evaluating the risks.

Authors:  J M Pellock
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 2.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

3.  Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.

Authors:  Beatrice Drexler; Felicitas Zurbriggen; Tamara Diesch; Romaine Viollier; Joerg P Halter; Dominik Heim; Andreas Holbro; Laura Infanti; Andreas Buser; Sabine Gerull; Michael Medinger; André Tichelli; Jakob R Passweg
Journal:  Ann Hematol       Date:  2020-09-19       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.